Y-Intercept (HK)’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-26,888
Closed -$1.97M – 1820
2026
Q2
$1.97M Buy
+26,888
New +$1.85M 0.04% 719
2026
Q1
– Sell
-11,359
Closed -$902K – 1795
2025
Q4
$902K Sell
11,359
-31,928
-74% -$2.7M 0.02% 1017
2025
Q3
$2.86M Buy
43,287
+33,905
+361% +$2.02M 0.07% 424
2025
Q2
$497K Buy
+9,382
New +$441K 0.01% 1204
2024
Q4
– Sell
-9,057
Closed -$445K – 1416
2024
Q3
$445K Buy
+9,057
New +$425K 0.03% 835
2024
Q1
– Sell
-9,844
Closed -$569K – 1560
2023
Q4
$569K Buy
+9,844
New +$504K 0.05% 539

Other funds holding IRON

Y-Intercept (HK)'s IRON Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Disc Medicine (IRON) in Q3 2026, closing a stake of 26,888 shares — an estimated $1.97M sold.

Y-Intercept (HK) first reported a position in IRON in Q4 2023 and held it in 6 quarters. The position peaked at $2.86M in Q3 2025. 33 funds tracked by Wall St. Rank hold IRON as of Q3 2026.

  • Y-Intercept (HK) reported no remaining Disc Medicine position as of Q3 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 26,888 Disc Medicine shares in Q3 2026, an estimated $1.97M.
  • Y-Intercept (HK) first reported a position in Disc Medicine in Q4 2023 and held it in 6 quarters.
  • Y-Intercept (HK)'s Disc Medicine position peaked at $2.86M in Q3 2025.
  • 33 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.